CAPTRUST Financial Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,760
| Closed | -$389K | – | 2477 |
|
|
2023
Q4 | $389K | Sell |
12,760
-6,605
| -34% | -$201K | ﹤0.01% | 1932 |
|
|
2023
Q3 | $612K | Buy |
19,365
+2,288
| +13% | +$72.3K | ﹤0.01% | 1510 |
|
|
2023
Q2 | $696K | Buy |
17,077
+3,655
| +27% | +$149K | ﹤0.01% | 1434 |
|
|
2023
Q1 | $500K | Sell |
13,422
-715
| -5% | -$26.6K | ﹤0.01% | 1409 |
|
|
2022
Q4 | $493K | Sell |
14,137
-103
| -0.7% | -$3.59K | ﹤0.01% | 1340 |
|
|
2022
Q3 | $797K | Buy |
14,240
+3,770
| +36% | +$211K | ﹤0.01% | 1035 |
|
|
2022
Q2 | $542K | Sell |
10,470
-2,145
| -17% | -$111K | ﹤0.01% | 1107 |
|
|
2022
Q1 | $917K | Sell |
12,615
-8,155
| -39% | -$593K | 0.01% | 883 |
|
|
2021
Q4 | $2.46M | Buy |
20,770
+3,625
| +21% | +$429K | 0.02% | 515 |
|
|
2021
Q3 | $2.3M | Buy |
17,145
+2,351
| +16% | +$315K | 0.02% | 491 |
|
|
2021
Q2 | $2.4M | Sell |
14,794
-449
| -3% | -$72.7K | 0.02% | 449 |
|
|
2021
Q1 | $1.22M | Buy |
15,243
+12,065
| +380% | +$968K | 0.01% | 624 |
|
|
2020
Q4 | $173K | Buy |
3,178
+2,725
| +602% | +$148K | ﹤0.01% | 1258 |
|
|
2020
Q3 | $9K | Buy |
453
+400
| +755% | +$7.95K | ﹤0.01% | 2332 |
|
|
2020
Q2 | $1K | Buy |
+53
| New | +$1K | ﹤0.01% | 2733 |
|
|
2018
Q4 | – | Sell |
-257
| Closed | -$7K | – | 1644 |
|
|
2018
Q3 | $7K | Sell |
257
-118
| -31% | -$3.21K | ﹤0.01% | 1301 |
|
|
2018
Q2 | $10K | Buy |
+375
| New | +$10K | ﹤0.01% | 1174 |
|